Mechanisms of soluble cytokine receptor generation

Journal of Immunology

Volumn 173, Issue 9, 2004, Pages 5343-5348

  Levine, Stewart J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CYTOKINE; CYTOKINE RECEPTOR; GLYCOSYLPHOSPHATIDYLINOSITOL; RECEPTOR PROTEIN;

GENETIC TRANSCRIPTION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; MAMMAL; MEMBRANE VESICLE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; REGULATORY MECHANISM; RNA SPLICING; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 6344268944     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.9.5343     Document Type: Short Survey

References (113)

1. Hull, K. M., E. Drewe, I. Aksentijevich, H. K. Singh, K. Wong, E. M. McDermott, J. Dean, R. J. Powell, and D. L. Kastner. 2002. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine 81:349.
2. Olsen, N. J., and C. M. Stein. 2004. New drugs for rheumatoid arthritis. N. Engl. J. Med. 350:2167.
3. Junghans, R. P., and T. A. Waldmann. 1996. Metabolism of Tac (IL2Rα): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding. J. Exp. Med. 183:1587.
4. Rubin, L. A., C. C. Kurman, M. E. Fritz, W. E. Biddison, B. Boutin, R. Yarchoan, and D. L. Nelson. 1985. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J. Immunol. 135:3172.
5. Greenfeder, S. A., P. Nunes, L. Kwee, M. Labow, R. A. Chizzonite, and G. Ju. 1995. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270:13757.
6. Dunne, A., and L. A. O'Neill. 2003. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. Signal Transduction Knowledge Environment 2003:re3.
7. Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J. G. Giti, S. K. Dower, J. E. Sims, and A. Mantovani. 1993. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261:472.
8. Malinowsky, D., J. Lundkvist, S. Laye, and T. Bartfai. 1998. Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor. FEBS Lett. 429:299.
9. Lang, D., J. Knop, H. Wesche, U. Raffetseder, R. Kuttle, D. Boraschi, and M. U. Martin. 1998. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J. Immunol. 161:6871.
10. Orlando, S., M. Sironi, G. Bianchi, A. H. Drummond, D. Boraschi, D. Yabes, and A. Mantovani. 1997. Role of metalloproteases in the release of the IL-1 type II decoy receptor. J. Biol. Chem. 272:31764.
11. Giri, J. G., J. Wells, S. K. Dower, C. E. McCall, R. N. Guzman, J. Slack, T. A. Bird, K. Shanebeck, K. H. Grabstein, J. E. Sims, et al. 1994. Elevated levels of shed type II IL-1 receptor in sepsis: potential role for type II receptor in regulation of IL-1 responses. J. Immunol. 153:5802.
12. Smith, D. E., R. Hanna, F. Della, H. Moore, H. Chen, A. M. Farese, T. J. MacVittie, G. D. Virca, and J. E. Sims. 2003. The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. Immunity 18:87.
13. Symons, J. A., P. R. Young, and G. W. Duff. 1995. Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1β precursor and loses affinity for IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 92:1714.
14. Horiuchi, S., Y. Koyanagi, Y. Zhou, H. Miyamoto, Y. Tanaka, M. Waki, A. Matsumoto, M. Yamamoto, and N. Yamamoto. 1994. Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur. J. Immunol. 24:1945.
15. Mullberg, J., H. Schooltink, T. Stoyan, M. Gunther, L. Graeve, G. Buse, A. Mackiewicz, P. C. Heinrich, and S. Rose-John. 1993. The soluble interleukin-6 receptor is generated by shedding. Eur. J. Immunol. 23:473.
16. Peters, M., S. Jacobs, M. Ehlers, P. Vollmer, J. Mullberg, E. Wolf, G. Brem, K. H. Meyer zum Buschenfelde, and S. Rose-John. 1996. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J. Exp. Med. 183:1399.
17. Rose-John, S., and M. F. Neurath. 2004. IL-6 trans-signaling: the heat is on. Immunity 20:2.
18. Hurst, S. M., T. S. Wilkinson, R. M. McLoughlin, S. Jones, S. Horiuchi, N. Yamamoto, S. Rose-John, G. M. Fuller, N. Topley, and S. A. Jones. 2001. Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 14:705.
19. Chen, Q., W. C. Wang, R. Bruce, H. Li, D. M. Schleider, M. J. Mulbury, M. D. Bain, P. K. Wallace, H. Baumann, and S. S. Evans. 2004. Central role of IL-6 receptor signal-transducing chain gp130 in activation of L-selectin adhesion by fever-range thermal stress. Immunity 20:59.
20. Jostock, T., J. Mullberg, S. Ozbek, R. Atreya, G. Blinn, N. Voltz, M. Fischer, M. F. Neurath, and S. Rose-John. 2001. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur. J. Biochem. 268:160.
21. Black, R. A. 2002. Tumor necrosis factor-α converting enzyme. Int J. Biochem. Cell Biol. 34:1.
22. Blobel, C. P. 2000. Remarkable roles of proteolysis on and beyond the cell surface. Curr. Opin. Cell Biol. 12:606.
23. Moss, M. L., and J. W. Bartsch. 2004. Therapeutic benefits from targeting of ADAM family members. Biochemistry 43:7227.
24. Black, R. A., C. T. Rauch, C. J. Kozlosky, J. J. Peschon, J. L. Slack, M. F. Wolfson, B. J. Castner, K. L. Stocking, P. Reddy, S. Srinivasan, et al. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 385:729.
25. Moss, M. L., S. L. Jin, M. E. Milla, D. M. Bickett, W. Burkhart, H. L. Carter, W. J. Chen, W. C. Clay, J. R. Didsbury, D. Hassler, et al. 1997. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385:733.
26. Peschon, J. J., J. L. Slack, P. Reddy, K. L. Stocking, S. W. Sunnarborg, D. C. Lee, W. E. Russell, B. J. Castner, R. S. Johnson, J. N. Fitzner, et al. 1998. An essential role for ectodomain shedding in mammalian development. Science 282:1281.
27. Reddy, P., J. L. Slack, R. Davis, D. P. Cerretti, C. J. Kozlosky, R. A. Blanton, D. Shows, J. J. Peschon, and R. A. Black. 2000. Functional analysis of the domain structure of tumor necrosis factor-α converting enzyme. J. Biol. Chem. 275:14608.
28. Hansen, H. P., S. Dietrich, T. Kisseleva, T. Mokros, R. Mentlein, H. H. Lange, G. Murphy, and H. Lemke. 2000. CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-α-converting enzyme. J. Immunol. 165:6703.
29. Contin, C., V. Pitard, T. Itai, S. Nagata, J. F. Moreau, and J. Dechanet-Merville. 2003. Membrane-anchored CD40 is processed by the tumor necrosis factor-α-converting enzyme: implications for CD40 signaling. J. Biol. Chem. 278:32801.
30. Althoff, K., P. Reddy, N. Voltz, S. Rose-John, and J. Mullberg. 2000. Shedding of interleukin-6 receptor and tumor necrosis factor α: contribution of the stalk sequence to the cleavage pattern of transmembrane proteins. Eur. J. Biochem. 267:2624.
31. Budagian, V., E. Bulanova, Z. Orinska, A. Ludwig, S. Rose-John, P. Saftig, E. C. Borden, and S. Bulfone-Paus. 2004. Natural soluble IL-15Rα is generated by cleavage that involves the tumor necrosis factor-α- converting enzyme (TACE/ADAM17). J. Biol. Chem. 279:40368.
32. Cruz, A. C., B. T. Frank, S. T. Edwards, P. F. Dazin, J. J. Peschon, and K. C. Fang. 2004. Tumor necrosis factor-α-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cells. J. Biol. Chem. 279:5612.
33. Rovida, E., A. Paccagnini, M. Del Rosso, J. Peschon, and P. Dello Sbarba. 2001. TNF-α-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation. J. Immunol. 166:1583.
34. Rio, C., J. D. Buxbaum, J. J. Peschon, and G. Corfas. 2000. Tumor necrosis factor-α-converting enzyme is required for cleavage of erbB4/HER4. J. Biol. Chem. 275:10379.
35. Weskamp, G., J. Schlondorff, L. Lum, J. D. Becherer, T. W. Kim, P. Saftig, D. Hartmann, G. Murphy, and C. P. Blobel. 2004. Evidence for a critical role of the tumor necrosis factor α convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR). J. Biol. Chem. 279:4241.
36. Zhang, Y., J. Jiang, R. A. Black, G. Baumann, and S. J. Frank. 2000. Tumor necrosis factor-α converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: the metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation. Endocrinology 141:4342.
37. Garton, K. J., P. J. Gough, J. Philalay, P. T. Wille, C. P. Blobel, R. H. Whitehead, P. J. Dempsey, and E. W. Raines. 2003. Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-α-converting enzyme (ADAM 17). J. Biol. Chem. 278:37459.
38. Tsou, C. L., C. A. Haskell, and I. F. Charo. 2001. Tumor necrosis factor-α-converting enzyme mediates the inducible cleavage of fractalkine. J. Biol. Chem. 276:44622.
39. Garton, K. J., P. J. Gough, C. P. Blobel, G. Murphy, D. R. Greaves, P. J. Dempsey, and E. W. Raines. 2001. Tumor necrosis factor-α-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J. Biol. Chem. 276:37993.
40. Hundhausen, C., D. Misztela, T. A. Berkhout, N. Broadway, P. Saftig, K. Reiss, D. Hartmann, F. Fahrenholz, R. Postina, V. Matthews, K. J. Kallen, S. Rose-John, and A. Ludwig. 2003. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102:1186.
41. Lum, L., B. R. Wong, R. Josien, J. D. Becherer, H. Erdjument-Bromage, J. Schlondorff, P. Tempst, Y. Choi, and C. P. Blobel. 1999. Evidence for a role of a tumor necrosis factor-α (TNF-α)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J. Biol. Chem. 274:13613.
42. Zhang, Z., P. Oliver, J. J. Lancaster, P. O. Schwarzenberger, M. S. Joshi, J. Cork, and J. K. Kolls. 2001. Reactive oxygen species mediate tumor necrosis factor α-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J. 15:303.
43. Zhang, Z., J. K. Kolls, P. Oliver, D. Good, P. O. Schwarzenberger, M. S. Joshi, J. L. Ponthier, and J. R. Lancaster, Jr. 2000. Activation of tumor necrosis factor-α-converting enzyme-mediated ectodomain shedding by nitric oxide. J. Biol. Chem. 275:15839.
44. Prenzel, N., E. Zwick, H. Daub, M. Leserer, R. Abraham, C. Wallasch, and A. Ullrich. 1999. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402:884.
45. Ludeman, M. J., Y. W. Zheng, K. Ishii, and S. R. Coughlin. 2004. Regulated shedding of PAR1 N-terminal exodomain from endothelial cells. J. Biol. Chem. 279:18592.
46. Diaz-Rodriguez, E., J. C. Montero, A. Esparis-Ogando, L. Yuste, and A. Pandiella. 2002. Extracellular signal-regulated kinase phosphorylates tumor necrosis factor α-converting enzyme at threonine 735: a potential role in regulated shedding. Mol. Biol. Cell. 13:2031.
47. Fan, H., C. W. Turck, and R. Derynck. 2003. Characterization of growth factor-induced serine phosphorylation of tumor necrosis factor-α converting enzyme and of an alternatively translated polypeptide. J. Biol. Chem. 278:18617.
48. Zheng, Y., J. Schlondorff, and C. P. Blobel. 2002. Evidence for regulation of the tumor necrosis factor α-convertase (TACE) by protein-tyrosine phosphatase PTPH1. J. Biol. Chem. 277:42463.
49. Nelson, K. K., J. Schlondorff, and C. P. Blobel. 1999. Evidence for an interaction of the metalloprotease-disintegrin tumour necrosis factor α convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease-disintegrin MDC9 with a novel MAD2-related protein, MAD2β. Biochem. J. 343:673.
50. Peiretti, F., P. Deprez-Beauclair, B. Bonardo, H. Aubert, I. Juhan-Vague, and G. Nalbone. 2003. Identification of SAP97 as an intracellular binding partner of TACE. J. Cell Sci. 116:1949.
51. Doedens, J. R., and R. A. Black. 2000. Stimulation-induced down-regulation of tumor necrosis factor-α converting enzyme. J. Biol. Chem. 275:14598.
52. Doedens, J. R., R. M. Mahimkar, and R. A. Black. 2003. TACE/ADAM-17 enzymatic activity is increased in response to cellular stimulation. Biochem. Biophys. Res. Commun. 308:331.
53. von Tresckow, B., K. J. Kallen, E. P. von Strandmann, P. Botchmann, H. Lange, A. Engert, and H. P. Hansen. 2004. Depletion of cellular cholesterol and lipid rafts increases shedding of CD30. J. Immunol. 172:4324.
54. Matthews, V., B. Schuster, S. Schutze, I. Bussmeyer, A. Ludwig, C. Hundhausen, T. Sadowski, P. Saftig, D. Hartmann, K. J. Kallen, and S. Rose-John. 2003. Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE). J. Biol. Chem. 278:38829.
55. Hinkle, C. L., S. W. Sunnarborg, D. Loiselle, C. E. Parker, M. Stevenson, W. E. Russell, and D. C. Lee. 2004. Selective roles for tumor necrosis factor α-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency. J. Biol. Chem. 279:24179.
56. Fourie, A. M., F. Coles, V. Moreno, and L. Karlsson. 2003. Catalytic activity of ADAM8, ADAM15, and MDC-L (ADAM28) on synthetic peptide substrates and in ectodomain cleavage of CD23. J. Biol. Chem. 278:30469.
57. Abel, S., C. Hundhausen, R. Mentlein, A. Schulte, T. A. Berkhout, N. Broadway, D. Hartmann, R. Sedlacek, S. Dietrich, B. Muetze, B. Schuster, K. J. Kallen, P. Saftig, S. Rose-John, and A. Ludwig. 2004. The transmembrane CXC-chemokine ligand 16 is induced by IFN-γ and TNF-α and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J. Immunol. 172:6362.
58. Gough, P. J., K. J. Garton, P. T. Wille, M. Rychlewski, P. J. Dempsey, and E. W. Raines. 2004. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J. Immunol. 172:3678.
59. Sahin, U., G. Weskamp, K. Kelly, H. M. Zhou, S. Higashiyama, J. Peschon, D. Hartmann, P. Saftig, and C. P. Blobel. 2004. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 164:769.
60. Murai, T., Y. Miyazaki, H. Nishinakamura, K. N. Sugahara, T. Miyauchi, Y. Sako, T. Yanagida, and M. Miyasaka. 2004. Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration. J. Biol. Chem. 279:4541.
61. 2+ influx and PKC activation. J. Cell Biol. 165:893.
62. Koolwijk, P., N. Sidenius, E. Peters, C. F. Sier, R. Hanemaaijer, F. Blasi, and V. W. van Hinsbergh. 2001. Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices. Blood 97:3123.
63. Kajita, M., Y. Itoh, T. Chiba, H. Mori, A. Okada, H. Kinoh, and M. Seiki. 2001. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J. Cell Biol. 153:893.
64. Velasco-Loyden, G., J. Arribas, and F. Lopez-Casillas. 2004. The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1. J. Biol. Chem. 279:7721.
65. Mosley, B., M. P. Beckmann, C. J. March, R. L. Idzerda, S. D. Gimpel, T. VandenBos, D. Friend, A. Alpert, D. Anderson, J. Jackson, et al. 1989. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 59:335.
66. Goodwin, R. G., D. Friend, S. F. Ziegler, R. Jerzy, B. A. Falk, S. Gimpel, D. Cosman, S. K. Dower, C. J. March, A. E. Namen, et al. 1990. Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily. Cell 60:941.
67. Renauld, J. C., C. Druez, A. Kermouni, F. Houssiau, C. Uyttenhove, E. Van Roost, and J. Van Snick. 1992. Expression cloning of the murine and human interleukin 9 receptor cDNAs. Proc. Natl. Acad. Sci. USA 89:5690.
68. Tavernier, J., T. Tuypens, G. Plaetinck, A. Verhee, W. Fiers, and R. Devos. 1992. Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor α subunit. Proc. Natl. Acad. Sci. USA 89:7041.
69. Fukunaga, R., Y. Seto, S. Mizushima, and S. Nagata. 1990. Three different mRNAs encoding human granulocyte colony-stimulating factor receptor. Proc. Natl. Acad. Sci. USA 87:8702.
70. Raines, M. A., L. Liu, S. G. Quan, V. Joe, J. F. DiPersio, and D. W. Golde. 1991. Identification and molecular cloning of a soluble human granulocyte-macrophage colony-stimulating factor receptor. Proc. Natl. Acad. Sci. USA 88:8203.
71. Lust, J. A., K. A. Donovan, M. P. Kline, P. R. Greipp, R. A. Kyle, and N. J. Maihle. 1992. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 4:96.
72. Diamant, M., K. Rieneck, N. Mechti, X. G. Zhang, M. Svenson, K. Bendtzen, and B. Klein. 1997. Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130. FEBS Lett. 412:379.
73. Arcasoy, M. O., X. Jiang, and Z. A. Haroon. 2003. Expression of erythropoietin receptor splice variants in human cancer. Biochem. Biophys. Res. Commun. 307:999.
74. Owczarek, C. M., M. J. Layton, L. G. Robb, N. A. Nicola, and C. G. Begley. 1996. Molecular basis of the soluble and membrane-bound forms of the murine leukemia inhibitory factor receptor α-chain: expression in normal, gestating, and leukemia inhibitory factor nullizygous mice. J. Biol. Chem. 271:5495.
75. Abramovich, C., E. Ratovitski, E. Lundgren, and M. Revel. 1994. Identification of mRNAs encoding two different soluble forms of the human interferon α-receptor. FEBS Lett. 338:295.
76. Jensen, L. E., M. Muzio, A. Mantovani, and A. S. Whitehead. 2000. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein. J. Immunol. 164:5277.
77. Liu, C., R. P. Hart, X. J. Liu, W. Clevenger, R. A. Maki, and E. B. De Souza. 1996. Cloning and characterization of an alternatively processed human type II interleukin-1 receptor mRNA. J. Biol. Chem. 271:20965.
78. Choi, M. E. 1999. Cloning and characterization of a naturally occurring soluble form of TGF-β type I receptor. Am. J. Physiol. 276:F88.
79. Roberts, H. J., S. Hu, Q. Qiu, P. C. Leung, I. Caniggia, A. Gruslin, B. Tsang, and C. Peng. 2003. Identification of novel isoforms of activin receptor-like kinase 7 (ALK7) generated by alternative splicing and expression of ALK7 and its ligand, Nodal, in human placenta. Biol. Reprod. 68:1719.
80. Michel, J., J. Langstein, F. Hofstadter, and H. Schwarz. 1998. A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis. Eur. J. Immunol. 28:290.
81. Hughes, D. P., and I. N. Crispe. 1995. A naturally occurring soluble isoform of murine Fas generated by alternative splicing. J. Exp. Med. 182:1395.
82. Haudenschild, D., T. Moseley, L. Rose, and A. H. Reddi. 2002. Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer. J. Biol. Chem. 277:4309.
83. Pitti, R. M., S. A. Marsters, D. A. Lawrence, M. Roy, F. C. Kischkel, P. Dowd, A. Huang, C. J. Donahue, S. W. Sherwood, D. T. Baldwin, et al. 1998. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396:699.
84. Yu, K. Y., B. Kwon, J. Ni, Y. Zhai, R. Ebner, and B. S. Kwon. 1999. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J. Biol. Chem. 274:13733.
85. Migone, T. S., J. Zhang, X. Luo, L. Zhuang, C. Chen, B. Hu, J. S. Hong, J. W. Perry, S. F. Chen, J. X. Zhou, et al. 2002. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16:479.
86. Sung, H. H., J. H. Juang, Y. C. Lin, C. H. Kuo, J. T. Hung, A. Chen, D. M. Chang, S. Y. Chang, S. L. Hsieh, and H. K. Sytwu. 2004. Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice. J. Exp. Med. 199:1143.
87. Yang, C. R., S. L. Hsieh, C. M. Teng, F. M. Ho, W. L. Su, and W. W. Lin. 2004. Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action. Cancer Res. 64:1122.
88. Zhang, J., T. W. Salcedo, X. Wan, S. Ullrich, B. Hu, T. Gregorio, P. Feng, S. Qi, H. Chen, Y. H. Cho, et al. 2001. Modulation of T-cell responses to alloantigens by TR6/DcR3. J. Clin. Invest. 107:1459.
89. Shi, G., Y. Wu, J. Zhang, and J. Wu. 2003. Death decoy receptor TR6/DcR3 inhibits T cell chemotaxis in vitro and in vivo. J. Immunol. 171:3407.
90. Simonet, W. S., D. L. Lacey, C. R. Dunstan, M. Kelley, M. S. Chang, R. Luthy, H. Q. Nguyen, S. Wooden, L. Bennett, T. Boone, et al. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309.
91. Dumoutier, L., D. Lejeune, D. Colau, and J. C. Renauld. 2001. Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22. J. Immunol. 166:7090.
92. Kotenko, S. V., L. S. Izotova, O. V. Mirochnitchenko, E. Esterova, H. Dickensheets, R. P. Donnelly, and S. Pestka. 2001. Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J. Immunol. 166:7096.
93. Xu, W., S. R. Presnell, J. Parrish-Novak, W. Kindsvogel, S. Jaspers, Z. Chen, S. R. Dillon, Z. Gao, T. Gilbert, K. Madden, et al. 2001. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc. Natl. Acad. Sci. USA 98:9511.
94. Novick, D., S. H. Kim, G. Fantuzzi, L. L. Reznikov, C. A. Dinatello, and M. Rubinstein. 1999. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10:127.
95. Théry, C., L. Zitvogel, and S. Amigorena. 2002. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2:569.
96. Hawati, F. I., F. N. Rouhani, X. Cui, Z. X. Yu, C. Buckley, M. Kaler, and S. J. Levine. 2004. Release of full-length 55-kDa TNF receptor 1 in exosome-like vesicles: a mechanism for generation of soluble cytokine receptors. Proc. Natl. Acad. Sci. USA 101:1297.
97. Andreola, G., L. Rivoltini, C. Castelli, V. Huber, P. Perego, P. Deho, P. Squarcina, P. Accotneto, F. Lozupone, L. Lugini, et al. 2002. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J. Exp. Med. 195:1303.
98. Davis, S., T. H. Aldrich, D. M. Valenzuela, V. V. Wong, M. E. Furth, S. P. Squinto, and G. D. Yancopoulos. 1991. The receptor for ciliary neurotrophic factor. Science 253:59.
99. Davis, S., T. H. Aldrich, N. Y. Ip, N. Stahl, S. Scheter, T. Farruggella, P. S. DiStefano, R. Curtis, N. Panayotatos, H. Gascan, et al. 1993. Released form of CNTF receptor α component as a soluble mediator of CNTF responses. Science 259:1736.
100. Cunnion, K. M. 1999. Tumor necrosis factor receptors encoded by poxviruses. Mol. Genet. Metab. 67:278.
101. Smith, C. A., T. Davis, D. Anderson, L. Solam, M. P. Beckmann, R. Jerzy, S. K. Dower, D. Cosman, and R. G. Goodwin. 1990. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019.
102. Upton, C., J. L. Macen, M. Schreiber, and G. McFadden. 1991. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 184:370.
103. Hu, F. Q., C. A. Smith, and D. J. Pickup. 1994. Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology 204:343.
104. Loparev, V. N., J. M. Parsons, J. C. Knight, J. F. Panus, C. A. Ray, R. M. Buller, D. J. Pickup, and J. J. Esposito. 1998. A third distinct tumor necrosis factor receptor of orthopoxviruses. Proc. Natl. Acad. Sci. USA 95:3786.
105. Smith, C. A., F. Q. Hu, T. D. Smith, C. L. Richards, P. Smolak, R. G. Goodwin, and D. J. Pickup. 1996. Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LTα. Virology 223:132.
106. Saraiva, M., and A. Alcami. 2001. CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses. J. Virol. 75:226.
107. Panus, J. F., C. A. Smith, C. A. Ray, T. D. Smith, D. D. Patel, and D. J. Pickup. 2002. Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family, a soluble, secreted CD30 homologue. Proc. Natl. Acad. Sci. USA 99:8348.
108. Saraiva, M., P. Smith, P. G. Fallon, and A. Alcami. 2002. Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus. J. Exp. Med. 196:829.
109. Symons, J. A., A. Alcami, and G. L. Smith. 1995. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81:551.
110. Colamonici, O. R., P. Domanski, S. M. Sweitzer, A. Larner, and R. M. Buller. 1995. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon α transmembrane signaling. J. Biol. Chem. 270:15974.
111. Upton, C., K. Mossman, and G. McFadden. 1992. Encoding of a homolog of the IFN-γ receptor by myxoma virus. Science 258:1369.
112. Alcami, A., and G. L. Smith. 1992. A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71:153.
113. Spriggs, M. K., D. E. Hruby, C. R. Maliszewski, D. J. Pickup, J. E. Sims, R. M. Buller, and J. VanSlyke. 1992. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71:145.